Single cell analysis of cribriform prostate cancer reveals cell intrinsic and tumor microenvironmental pathways of aggressive disease

HY Wong, Q Sheng, AB Hesterberg… - Nature …, 2022 - nature.com
Cribriform prostate cancer, found in both invasive cribriform carcinoma (ICC) and intraductal
carcinoma (IDC), is an aggressive histological subtype that is associated with progression to …

A prostate cancer “nimbosus”: genomic instability and SChLAP1 dysregulation underpin aggression of intraductal and cribriform subpathologies

MLK Chua, W Lo, M Pintilie, J Murgic, E Lalonde… - European urology, 2017 - Elsevier
Background Intraductal carcinoma (IDC) and cribriform architecture (CA) represent
unfavorable subpathologies in localized prostate cancer. We recently showed that IDC …

Genetic and epigenetic determinants of aggressiveness in cribriform carcinoma of the prostate

H Elfandy, J Armenia, F Pederzoli, E Pullman… - Molecular Cancer …, 2019 - AACR
Among prostate cancers containing Gleason pattern 4, cribriform morphology is associated
with unfavorable clinicopathologic factors, but its genetic features and association with long …

Cribriform prostate cancer: clinical pathologic and molecular considerations

AB Hesterberg, JB Gordetsky, PJ Hurley - Urology, 2021 - Elsevier
Intraductal cribriform (IDC) and invasive cribriform morphologies are associated with worse
prostate cancer outcomes. Limited retrospective studies have associated IDC and cribriform …

Bimodal CD40/Fas-dependent crosstalk between iNKT cells and tumor-associated macrophages impairs prostate cancer progression

F Cortesi, G Delfanti, A Grilli, A Calcinotto, F Gorini… - Cell reports, 2018 - cell.com
Heterotypic cellular and molecular interactions in the tumor microenvironment (TME) control
cancer progression. Here, we show that CD1d-restricted invariant natural killer (iNKT) cells …

Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations

R Böttcher, CF Kweldam, J Livingstone, E Lalonde… - BMC cancer, 2018 - Springer
Background Invasive cribriform and intraductal carcinoma (CR/IDC) is associated with
adverse outcome of prostate cancer patients. The aim of this study was to determine the …

[HTML][HTML] Advances in landscape and related therapeutic targets of the prostate tumor microenvironment: Therapeutic targets of the prostate tumor microenvironment

D Li, W Xu, Y Chang, Y Xiao, Y He… - Acta Biochimica et …, 2023 - ncbi.nlm.nih.gov
The distinct tumor microenvironment (TME) of prostate cancer (PCa), which promotes tumor
proliferation and progression, consists of various stromal cells, immune cells, and a dense …

Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses

T Hirz, S Mei, H Sarkar, Y Kfoury, S Wu… - Nature …, 2023 - nature.com
The treatment of low-risk primary prostate cancer entails active surveillance only, while high-
risk disease requires multimodal treatment including surgery, radiation therapy, and …

Immune cell analyses of the tumor microenvironment in prostate cancer highlight infiltrating regulatory T cells and macrophages as adverse prognostic factors

LB Andersen, M Nørgaard, M Rasmussen… - The Journal of …, 2021 - Wiley Online Library
Improved risk stratification is needed for patients with localized prostate cancer. This study
characterized and assessed the prognostic potential of distinct immune cell infiltration …

Targeting HIC1/TGF-β axis-shaped prostate cancer microenvironment restrains its progression

T Wu, W Wang, G Shi, M Hao, Y Wang, M Yao… - Cell Death & …, 2022 - nature.com
Prostate cancer (PCa) is a malignant tumor that seriously threatens men's health worldwide.
Recently, stromal cells in the tumor microenvironment (TME) have been reported to …